|
|
|
|
After 18 to 24 months,all symptoms except cognitive changes were reported to have improved in most patients.Nearly all physical findings were also reported to have improved or resolved in most patients;only peripheral neuropathy was unchanged.No evidence of ongoing inflammatory disease was reported.Prednisone was reported to be helpful in 79%of patients who received it during the acute phase of the syndrome.No other treatment was reported to be consistently beneficial.18 to 24 months after the onset of illness,most symptoms and physical findings in most patients with the eosinophilia-myalgia syndrome resolved or improved.Cognitive changes were reported to be worse in 32%of patients.Prednisone was helpful in the acute phase of illness.No treatment was clearly valuable in management of the later phase of the syndrome. |
|